Sustained-release diltiazem for stable angina pectoris.

From: American Family Physician | Date: August 1, 1990 | Copyright information

Diltiazem has been shown to be effective in the treatment of exertional angina pectoris. The recommended dose interval is six to eight hours, with a maximal daily dosage of 360 mg. Klinke and colleagues studied the safety and efficacy of sustained-release diltiazem with a twice-daily regimen.

A total of 80 patients with chronic stable angina were enrolled in the double-blind study. Eight patients were excluded for violating the study protocol, and seven withdrew prior to...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Clinical implications of depression in patients with cardiovascular disease.(Special Populations in Depression)
Internal Medicine News ; Depression--both major depressive disorder (MDD) and depressive symptoms--increases mortality in patients following myocardial infarction (MI) and also is a predictor of developing cardiovascular disease (CVD) in the general population free of any evidence of medical illness (1-4) Furthermore,
Are women better doctors? They listen more and give patients more say, studies find
Chicago Sun-Times ; KEYWORD-HIT.
Strategies for managing patients with migraine.(Disease/Disorder overview)
Internal Medicine News ; Migraine is a complex disorder with variations in freuency, intensity, and symptoms from person to person and from episode to episode. Although an estimated 28 million individuals (18% of women and 6% of men) in the United States experience migraine headaches, nearly half of this population are not
Lupus patients have extremely low levels of vitamin D.(Rheumatology)
Internal Medicine News ; NEW YORK -- Patients with lupus have dramatically low serum levels of the biologically active form of vitamin D, a deficiency that may contribute to the pathological processes involved in their disease, Dr. Peter E. Lipsky said at a rhematology meeting sponsored by New York University. Previous
Heart patients may be denied 'costly' lifesaver; Crucial decisions: Drug-eluting stents are dearer - but better.
The Daily Mail (London, England) ; Byline: Daniel Martin THOUSANDS of heart patients could be denied life-saving treatment after the NHS ruled yesterday that it costs too much. The decision to restrict drugcoated stents only to those most at risk of heart attacks could put lives in danger, critics warned. Around 40,000 people a year
NURSE ADMITS KILLING 13 PATIENTS
Chicago Sun-Times ; Caption text only.
Patients go on paying
South Wales Evening Post ; Patients in Neath and Port Talbot will miss out on the Assembly's free hospital parking pledge. Full story - page 9
Doctors to face tighter vetting; Attention will be paid to patients' views; CAMPAIGNER'S 'LASTING LEGACY'.(News)
The Journal (Newcastle, England) ; Byline: Jane Kirby DOCTORS will face more rigorous tests of their competence every year under plans announced by the Government yesterday. At present, all NHS trusts must appraise doctors annually but the Government wants to tighten this up. New annual assessments will take account of patient's
Avonex approved. (News).(by the FDA for patients with early multiple sclerosis)(Brief Article)
Chain Drug Review ; Avonex has been approved by the FDA for patients with early multiple sclerosis. The product was developed by Biogen Inc.
Two thirds of patients with Parkinson's disease admitted to hospital are not attended by a nurse specialist, according to a survey of 256 patients carried out by the Parkinson's Disease Society.
Nursing Standard ; Two thirds of patients with Parkinson's disease admitted to hospital are not attended by a nurse specialist, according to a survey of 256 patients carried out by the Parkinson's Disease Society. Most patients said that nursing staff had only a limited understanding of the disease.